238 related articles for article (PubMed ID: 21692070)
41. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer.
Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G
Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755
[No Abstract] [Full Text] [Related]
42. 17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk.
Soares R; Guo S; Gärtner F; Schmitt FC; Russo J
Angiogenesis; 2003; 6(4):271-81. PubMed ID: 15166495
[TBL] [Abstract][Full Text] [Related]
43. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis.
Ferrari G; Cook BD; Terushkin V; Pintucci G; Mignatti P
J Cell Physiol; 2009 May; 219(2):449-58. PubMed ID: 19180561
[TBL] [Abstract][Full Text] [Related]
45. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
[TBL] [Abstract][Full Text] [Related]
46. Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy.
Fathers KE; Stone CM; Minhas K; Marriott JJ; Greenwood JD; Dumont DJ; Coomber BL
Am J Pathol; 2005 Dec; 167(6):1753-62. PubMed ID: 16314485
[TBL] [Abstract][Full Text] [Related]
47. VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis.
Foersch S; Sperka T; Lindner C; Taut A; Rudolph KL; Breier G; Boxberger F; Rau TT; Hartmann A; Stürzl M; Wittkopf N; Haep L; Wirtz S; Neurath MF; Waldner MJ
Gastroenterology; 2015 Jul; 149(1):177-189.e10. PubMed ID: 25797700
[TBL] [Abstract][Full Text] [Related]
48. TGF beta1 expression and angiogenesis in colorectal cancer tissue.
Xiong B; Gong LL; Zhang F; Hu MB; Yuan HY
World J Gastroenterol; 2002 Jun; 8(3):496-8. PubMed ID: 12046078
[TBL] [Abstract][Full Text] [Related]
49. Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer.
Zhang J; Deng YT; Liu J; Gan L; Jiang Y
Cancer Biol Ther; 2024 Dec; 25(1):2366451. PubMed ID: 38857055
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
[TBL] [Abstract][Full Text] [Related]
51. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer.
Kim SL; Lee ST; Trang KT; Kim SH; Kim IH; Lee SO; Kim DG; Kim SW
Int J Mol Med; 2014 May; 33(5):1261-7. PubMed ID: 24573421
[TBL] [Abstract][Full Text] [Related]
52. TGFβ1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells.
Vittet D; Merdzhanova G; Prandini MH; Feige JJ; Bailly S
J Cell Physiol; 2012 Nov; 227(11):3593-602. PubMed ID: 22287283
[TBL] [Abstract][Full Text] [Related]
53. VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells.
Li D; Li XP; Wang HX; Shen QY; Li XP; Wen L; Qin XJ; Jia QL; Kung HF; Peng Y
Oncol Rep; 2012 Sep; 28(3):937-42. PubMed ID: 22711017
[TBL] [Abstract][Full Text] [Related]
54. Isolation and characterization of a new cell line from a renal carcinoma bone metastasis.
Avnet S; Cenni E; Granchi D; Perut F; Amato I; Battistelli L; Brandi ML; Giunti A; Baldini N
Anticancer Res; 2004; 24(3a):1705-11. PubMed ID: 15274344
[TBL] [Abstract][Full Text] [Related]
55. TGF-β promotes colorectal cancer cell growth in vitro and in vivo.
Sun G; Cao D; Sun Z; Zhou K; Wang Y; Liu H
Hepatogastroenterology; 2013 Jun; 60(124):715-9. PubMed ID: 23178467
[TBL] [Abstract][Full Text] [Related]
56. VEGFR2 regulates endothelial differentiation of colon cancer cells.
Liu Z; Qi L; Li Y; Zhao X; Sun B
BMC Cancer; 2017 Aug; 17(1):593. PubMed ID: 28854900
[TBL] [Abstract][Full Text] [Related]
57. [Relation of advanced oxidation protein products with VEGF and TGF-β1 in colon cancer cells exposed to intermittent hypoxia].
Xian LW; Li TP; Wei YE; Wu SP; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):619-23. PubMed ID: 21515455
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
[TBL] [Abstract][Full Text] [Related]
59. Let-7g improves multiple endothelial functions through targeting transforming growth factor-beta and SIRT-1 signaling.
Liao YC; Wang YS; Guo YC; Lin WL; Chang MH; Juo SH
J Am Coll Cardiol; 2014 Apr; 63(16):1685-94. PubMed ID: 24291274
[TBL] [Abstract][Full Text] [Related]
60. Sustained contraction and loss of NO production in TGFbeta1-treated endothelial cells.
Watanabe M; Oike M; Ohta Y; Nawata H; Ito Y
Br J Pharmacol; 2006 Oct; 149(4):355-64. PubMed ID: 16967050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
